{"entity":{"type":"insider","cik":"0001534986","url":"/insider/0001534986","json_url":"/insider/0001534986.json","name":"Siffert Joao MD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2012-05-14","last":"2022-12-21","span_basis":"filed_date"},"name_variants":[{"name":"Siffert Joao MD","source":"filing","n_filings":7,"first_seen":"2012-05-14","last_seen":"2022-12-21"}],"transactions":[{"id":6927366,"accession":"0001209191-22-062349","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-062349","line_url":"/filing/0001209191-22-062349#line-2","is_derivative":false,"issuer_cik":"0001534986","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001534986","owner_cik":"0001534986","owner_name":"Siffert Joao MD","owner_display_name":"Siffert Joao MD","owner_url":"/insider/0001534986","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6300.0,"shares_display":"6,300","price_per_share":8.375,"price_display":"8.38","price_state":"stated","total_value":52762.5,"total_display":"52,762.50","total_whole":"52,763","shares_owned_after":132619.0,"shares_owned_after_display":"132,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-21","scope":"insider"},{"id":6927363,"accession":"0001209191-22-062349","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062349","line_url":"/filing/0001209191-22-062349#line-1","is_derivative":false,"issuer_cik":"0001534986","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001534986","owner_cik":"0001534986","owner_name":"Siffert Joao MD","owner_display_name":"Siffert Joao MD","owner_url":"/insider/0001534986","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1150.0,"shares_display":"1,150","price_per_share":8.47,"price_display":"8.47","price_state":"stated","total_value":9740.5,"total_display":"9,740.50","total_whole":"9,741","shares_owned_after":126319.0,"shares_owned_after_display":"126,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-19","filed_date":"2022-12-21","scope":"insider"},{"id":6809359,"accession":"0001209191-14-077551","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-077551","line_url":"/filing/0001209191-14-077551#line-3","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001534986","owner_name":"Siffert Joao MD","owner_display_name":"Siffert Joao MD","owner_url":"/insider/0001534986","role":"Officer (SVP, R&D)","role_mark":"O","role_mark_label":"Officer (SVP, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15505.0,"shares_display":"15,505","price_per_share":16.93,"price_display":"16.93","price_state":"stated","total_value":262499.65,"total_display":"262,499.65","total_whole":"262,500","shares_owned_after":314192.0,"shares_owned_after_display":"314,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-18","filed_date":"2014-12-22","scope":"insider"},{"id":6448530,"accession":"0001209191-14-064840","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-064840","line_url":"/filing/0001209191-14-064840#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001534986","owner_name":"Siffert Joao MD","owner_display_name":"Siffert Joao MD","owner_url":"/insider/0001534986","role":"Officer (SVP, R&D)","role_mark":"O","role_mark_label":"Officer (SVP, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8426.0,"shares_display":"8,426","price_per_share":11.8,"price_display":"11.80","price_state":"stated","total_value":99426.8,"total_display":"99,426.80","total_whole":"99,427","shares_owned_after":222554.0,"shares_owned_after_display":"222,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-24","filed_date":"2014-10-24","scope":"insider"},{"id":6972253,"accession":"0001209191-14-038146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-038146","line_url":"/filing/0001209191-14-038146#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001534986","owner_name":"Siffert Joao MD","owner_display_name":"Siffert Joao MD","owner_url":"/insider/0001534986","role":"Officer (SVP, R&D)","role_mark":"O","role_mark_label":"Officer (SVP, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13547.0,"shares_display":"13,547","price_per_share":5.18,"price_display":"5.18","price_state":"stated","total_value":70173.46,"total_display":"70,173.46","total_whole":"70,173","shares_owned_after":230980.0,"shares_owned_after_display":"230,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-28","filed_date":"2014-05-30","scope":"insider"},{"id":5453816,"accession":"0001209191-13-058265","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-058265","line_url":"/filing/0001209191-13-058265#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001534986","owner_name":"Siffert Joao MD","owner_display_name":"Siffert Joao MD","owner_url":"/insider/0001534986","role":"Officer (SVP, R&D)","role_mark":"O","role_mark_label":"Officer (SVP, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5970.0,"shares_display":"5,970","price_per_share":2.632,"price_display":"2.63","price_state":"stated","total_value":15713.04,"total_display":"15,713.04","total_whole":"15,713","shares_owned_after":110230.0,"shares_owned_after_display":"110,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-18","filed_date":"2013-12-20","scope":"insider"},{"id":5540122,"accession":"0001209191-13-044974","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-044974","line_url":"/filing/0001209191-13-044974#line-2","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001534986","owner_name":"Siffert Joao MD","owner_display_name":"Siffert Joao MD","owner_url":"/insider/0001534986","role":"Officer (SVP, R&D)","role_mark":"O","role_mark_label":"Officer (SVP, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21094.0,"shares_display":"21,094","price_per_share":4.2177,"price_display":"4.22","price_state":"stated","total_value":88968.1638,"total_display":"88,968.16","total_whole":"88,968","shares_owned_after":116200.0,"shares_owned_after_display":"116,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-18","filed_date":"2013-09-19","scope":"insider"},{"id":2578366,"accession":"0001209191-12-027780","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-027780","line_url":"/filing/0001209191-12-027780#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001534986","owner_name":"Siffert Joao MD","owner_display_name":"Siffert Joao MD","owner_url":"/insider/0001534986","role":"Officer (SVP, R&D)","role_mark":"O","role_mark_label":"Officer (SVP, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, R&D","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2700.0,"shares_display":"2,700","price_per_share":2.96,"price_display":"2.96","price_state":"stated","total_value":7992.0,"total_display":"7,992.00","total_whole":"7,992","shares_owned_after":32200.0,"shares_owned_after_display":"32,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-10","filed_date":"2012-05-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001807120","name":"Design Therapeutics, Inc.","url":"/issuer/0001807120","role":"Director, Officer (President and CEO)","n_filings":1,"first_seen":"2022-12-21","last_seen":"2022-12-21"},{"type":"issuer","type_label":"ISSUER","cik":"0000858803","name":"AVANIR PHARMACEUTICALS, INC.","url":"/issuer/0000858803","role":"Officer (SVP, R&D)","n_filings":6,"first_seen":"2012-05-14","last_seen":"2014-12-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001534986","retrieved_at":"2026-08-24T21:41:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}